Home
Asepta

Akildia Crème Multi-Protectrice Pied Diabétique, 75ml

Dermo-adjuvant cream treatment for fragile feet, particularly for diabetic individuals. Helps combat severe dryness, roughness, and calluses.

Safety

True or false, at a glance

Free from CMR-classified ingredients?
To be confirmed

Composition incomplete on our side : absence not guaranteed.

Free from endocrine disruptors?
To be confirmed

Composition incomplete on our side : absence not guaranteed.

Free from fragrance allergens (Annex III)?
To be confirmed

Composition incomplete on our side : absence not guaranteed.

Fragrance-free?
To be confirmed

Composition incomplete on our side : absence not guaranteed.

This multi-protective cream is a dermo-adjuvant treatment formulated for fragile feet, particularly those of diabetic individuals. Its cream texture helps combat severe dryness, roughness, and calluses while promoting skin suppleness and firmness. It contains Shea Butter, Grape Seed Oil, Centella Asiatica, Ginkgo-Biloba, Silk Lipesters, and Glistin to preserve the skin flora and maintain the barrier function of the epidermis.

Ingredients

Composition

No contraindication is on record for the ingredients of this product. If in doubt, ask your pharmacist.

The brand

Asepta

🔒
Factual, sourced information. For your specific case, ask your pharmacist.
Sources
ANSMEUR-Lex — Commission européenneSCCS / PubMed (NCBI)Commission européenne — SCCSAmerican Cleaning Institute (ACI)Contact Dermatitis / PubMed (NCBI)Contact Dermatitis — Wiley Online LibraryCosmeticsDesign-Europe
Les produits cosmétiques non rincés contenant du phénoxyéthanol ne doivent pas être utilisés sur les fesses des enfants de 3 ans ou moins
ANSM ↗
Règlement (CE) n° 1223/2009 du Parlement européen et du Conseil relatif aux produits cosmétiques
EUR-Lex — Commission européenne ↗
Opinion of the Scientific Committee on Consumer Safety (SCCS) — Final version of the opinion on Phenoxyethanol in cosmetic products
SCCS / PubMed (NCBI) ↗
SCCS — Opinion on Phenoxyethanol (SCCS/1575/16, version 2021)
Commission européenne — SCCS ↗
Sodium Lauryl Sulfate (SLS) — Safety & CIR conclusions
American Cleaning Institute (ACI) ↗
Strengths and Limitations of Sodium Lauryl Sulfate as an Irritant Control in Patch Testing (Forkel et al., 2025)
Contact Dermatitis / PubMed (NCBI) ↗
Profile of irritant patch testing with detergents: sodium lauryl sulfate, sodium laureth sulfate and alkyl polyglucoside (Löffler, 2003)
Contact Dermatitis — Wiley Online Library ↗
Règlement (CE) n° 1223/2009 du Parlement européen et du Conseil relatif aux produits cosmétiques
EUR-Lex — Commission européenne ↗
Exploring EU regulations: SLS in cosmetics
CosmeticsDesign-Europe ↗
Trust

Transparency & method

Lou
Published on 16/11/2026Updated on 16/11/2026

How Lou builds its answers and chooses its sources →

Is this product right for you?

Lou analyses it with you based on your situation and preferences.

Analyse with Lou
Ask Lou a question